Salipro Biotech enters into a collaboration and license agreement with AbCellera
Salipro Biotech enters into a collaboration and license agreement with AbCellera for access to the Salipro® Platform for antibody discovery against GPCRs, ion channels, and transporters The collaboration enables AbCellera to access Salipro Biotech’s unique expertise and its Salipro® platform technology to generate stable antigens for challenging membrane protein drug targets for antibody discovery.Stockholm, Sweden, October 12, 2021 – Swedish biotech company Salipro Biotech AB today announced that it has entered into a collaboration and licensing agreement with AbCellera for access to